Literature DB >> 8166775

Congenital myotonic dystrophy; a report on thirteen cases and a review of the literature.

A T Hageman1, F J Gabreëls, K D Liem, K Renkawek, J M Boon.   

Abstract

The congenital variant of myotonic dystrophy (CMD) is a severe disease with a high mortality. CMD is only seen in the offspring of mothers who themselves have myotonic dystrophy (MD). We present 13 patients with clinical symptoms of CMD and neuropathological findings of five of them. The most characteristic symptoms during pregnancy are reduced fetal movements and polyhydramnios. In the neonatal period generalized hypotonia, facial weakness, hyporeflexia, feeding and respiratory difficulties are present. Most of the children have a characteristic tented upper lip. The symptoms greatly diminish after a few weeks. All the children who survive the neonatal period are psychomotor retarded. On pathological examination no specific features were found in muscle tissue or in the brain. The pathogenesis and the cause of the maternal inheritance of CMD is not clear. A review of the literature is provided.

Entities:  

Mesh:

Year:  1993        PMID: 8166775     DOI: 10.1016/0022-510x(93)90072-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  Neonatal neuroimaging findings in congenital myotonic dystrophy.

Authors:  T Bosemani; J Jasien; M V Johnston; T A G M Huisman; A Poretti; F J Northington
Journal:  J Perinatol       Date:  2014-02       Impact factor: 2.521

2.  Congenital myotonic dystrophy.

Authors:  S Gulati; M Kabra; S Gera; V Kalra; R Saxena; I C Verma
Journal:  Indian J Pediatr       Date:  2001-05       Impact factor: 1.967

Review 3.  Investigation of muscle disease.

Authors:  F L Mastaglia; N G Laing
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

4.  Congenital myotonic dystrophy in a national registry.

Authors:  Patrick Prendergast; Sandra Magalhaes; Craig Campbell
Journal:  Paediatr Child Health       Date:  2010-10       Impact factor: 2.253

5.  White matter abnormalities and neurocognitive correlates in children and adolescents with myotonic dystrophy type 1: a diffusion tensor imaging study.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Erin E Ward; Kelvin O Lim; John W Day
Journal:  Neuromuscul Disord       Date:  2010-12-18       Impact factor: 4.296

6.  Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1.

Authors:  Siham Ait Benichou; Dominic Jauvin; Thiéry De Serres-Bérard; Marion Pierre; Karen K Ling; C Frank Bennett; Frank Rigo; Genevieve Gourdon; Mohamed Chahine; Jack Puymirat
Journal:  Gene Ther       Date:  2022-01-25       Impact factor: 5.250

Review 7.  Congenital myotonic dystrophy: ventriculomegaly and shunt considerations for the pediatric neurosurgeon.

Authors:  Ian S Mutchnick; Meena A Thatikunta; William C Gump; Dan L Stewart; Thomas M Moriarty
Journal:  Childs Nerv Syst       Date:  2016-01-08       Impact factor: 1.475

8.  Myotonic dystrophy in a large Sicilian kinship: a case report.

Authors:  R Trifiletti; E Parano; R Falsaperla; G Incorpora
Journal:  Childs Nerv Syst       Date:  1995-08       Impact factor: 1.475

Review 9.  Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions.

Authors:  Genevieve Ho; Michael Cardamone; Michelle Farrar
Journal:  World J Clin Pediatr       Date:  2015-11-08

10.  Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.

Authors:  Lise Michel; Aline Huguet-Lachon; Geneviève Gourdon
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.